Gene Expression Market Analysis Report By Process, By Product, By Technique, By Capacity, By Application And Segment Forecasts From 2021 To 2028

Synopsis

The global gene expression market was prized by USD 9.07 billion in 2020. It is estimated to witness 9.96% CAGR from 2021 to 2028.

Drivers

The growth of technically sophisticated solutions is expected to offer the development opportunity to the market for gene expression. Increase in gene exp. revision to examine the threat variants of Covid-19 is likely to steer the global market for gene expression.

It has appeared like one of the important tools, utilized in a variety of functions like microbiology, clinical diagnostics, medicine detection as well as development actions, biotechnology, plus others. The implementation of these procedures, through diverse phases of the medicine invention procedure has augmented during the current years.

Technique Insight

The RNA exp. technique section held more than 41.0% revenue share and led the gene expression market, in 2020. Increase in speed of greater throughput technologies, for example RNA sequencing (RNA-seq), and cDNA microarray, frequently changes previous methods.

Therefore, technical progress in RNA exp. tools as well as techniques together with the accessibility of a variety of products, to fulfill diverse research requirements is expected to augment the implementation of these methods, designed for gene expression testing.
DNA microarrays plus PCR methods are the most important donor to the big share of this section because these procedures contain a major acceptance speed and have assisted researchers along with the biologists, to review terms of diverse genes as well as microbes.
By its greater speed and effectiveness, RT-PCR has carried innovatory transformation to the learning of gene expression. Besides, the higher versions of PCR, for example qPCR and digital PCR contain function in the analysis of comparative or differential expression. These developments in the PCR technology have augmented the implementation of PCR, intended for the RNA exp. study.

Capacity Insight

The High-Plex capacity section held the major, 64.2% revenue share of the market, in 2020. It is expected to maintain the leading place via rising by the highest CAGR, during the forecast period. A growth in the acceptance of gene expression scrutiny, meant for the several genomic reviews, is an input factor encouraging the expansion of the section.

Product Insight

The kits & reagents product division held, more than 74.0% revenue share and led the global gene expression market, in 2020. The existence of a greater number of companies, presenting diverse categories of kits & reagents used for the gene expression, is credited to greater share of the division.

The DNA chip/microarray division is anticipated to record the highest CAGR, during the forecast period because of the growth in the operation of DNA microarrays, used for the study of gene expression. Microarrays, makes possible the greater throughput gene expression study of big genome sets. Technical progressions in this subject have, furthermore, augmented the function of microarrays in biomedicine, diagnostics, medicine invention, plus additional biotechnology areas.

Process Insight

The cDNA synthesis & conversion process section held 27.06% revenue share and dominated the market, in 2020, because of the accessibility of an extensive variety of kits, designed for the cDNA synthesis to correspond the research requirements regarding the sample size, best possible response temperature and the figure of reactions. Besides, the growth in product presentation of cDNA synthesis and library preparation kits is expected to boost the development of the section.

The data analysis & interpretation section is projected to record the highest CAGR, during the forecast period. Companies contest to give the finest data analytics and interpretation outcomes for the gene expression arrays.

Larger investments in cancer connected research, in addition to necessity for the enhanced version software, meant for cancer gene expression, would speed up the development of the section. A variety of methods along with the algorithms are built up concentrating on gene expression analysis for the compound sicknesses.

Application Insight

The drug discovery & development section held the major, more than 41.0% revenue share of the gene expression market, in 2020. A growth in the investigation of gene exp. reports of SARS-CoV-2 receptors, meant for in silico medicine invention used for Covid-19, is the greater effect depicting driver for the section.

An augmentation in demand for the before time as well as precise analytical tests, meant for the compound sicknesses, is likely to impel the clinical diagnostics application section by the highest CAGR, during the forecast period.

The exercise of RNA expression in clinical diagnostics, to offer a before time as well as precise analysis of the Early-Onset Infection (EOI) and additional unusual genetic circumstances in premature babies, push the enlargement of the section.

The use of RNA exp. in clinical diagnostics, to provide an early and accurate diagnosis of the Early-Onset Infection (EOI) and other rare genetic conditions in preterm infants, drives segment growth.

Regional Insight

In 2020, North America detained the major, above 45.0% revenue share of the global gene expression market. This can be credited to the attendance of a large number of crucial companies, like Thermo Fisher Scientific, within the region. The major companies are constantly in the process of wide ranging R&D activities, to build up fresh methods and technology, which consist of gene expression scrutiny.

On account of the increasing attention of the leading companies in rising markets, like India and China, Asia Pacific is projected to be the highest rising local market, during the forecast period. Because of the augmented genomic as well as gene connected research, sequencing and array technologies are extensively taken on within this region.

Companies

The majority of the leading companies go along natural enlargement policy, to strengthen their existence in the market.

Some of the companies for gene expression market are:

• Interpace Biosciences, Inc.
• Biocartis NV
• ELITech Group
• Takara Bio, Inc.
• Promega Corp.
• Agilent Technologies
• Bio-Rad Laboratories
• Illumina, Inc.
• Quest Diagnostics, Inc.
• Fluidigm Corp.
• IntegraGen
• Auto Genomics
• Danaher Corp.
• Luminex Corp.
• GE Healthcare
• Thermo Fisher Scientific, Inc.
• PerkinElmer, Inc.
• F. Hoffmann-La Roche Ltd.
• QIAGEN

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2028. For the purpose of this study, Grand View Research has segmented the global gene expression market report on the basis of process, product, capacity, technique, application, and region:

• Process Outlook (Revenue, USD Million, 2017 - 2028)
    • Sample Collection
    • Purification
    • cDNA Synthesis & Conversion
    • PCR Analysis
    • Data Analysis & Interpretation

• Product Outlook (Revenue, USD Million, 2017 - 2028)
    • Kits & Reagents
    • DNA Chip/Microarray
    • Others

• Capacity Outlook (Revenue, USD Million, 2017 - 2028)
    • Low- to Mid-Plex
    • High-Plex

• Technique Outlook (Revenue, USD Million, 2017 - 2028)
    • RNA Exp.
        • Northern Blotting
        • DNA Microarrays
        • PCR Techniques
        • RNA-Seq
    • Promoter Analysis
        • In vitro Transcription/Nuclear Run-On Assays
        • Gel Shift Assays
        • Chromatin Immunoprecipitation (ChIP) Assays
    • Protein Exp. & Posttranslational Modification Analysis
        • Western Blotting
        • 2-D Gel Electrophoresis
        • Immunoassays
        • Mass Spectrometry

• Application Outlook (Revenue, USD Million, 2017 - 2028)
    • Drug Discovery & Development
    • Clinical Diagnostics
        • RNA Exp.
          • Other Techniques
    • Biotechnology & Microbiology
    • Others

• Regional Outlook (Revenue, USD Million, 2017 - 2028)
    • North America
        • U.S.
        • Canada
    • Europe
        • Germany
        • France
        • U.K.
        • Italy
        • Spain
    • Asia Pacific
        • Japan
        • China
        • India
        • Australia
        • South Korea
    • Latin America
        • Brazil
        • Mexico
    • Middle East Africa (MEA)
        • South Africa
        • Saudi Arabia